CANCERS, ISSN 2072-6694, 06/2019, Volume 11, Issue 7, p. 1035
The Wnt pathway is involved in the progression of breast cancer (BC). We aimed to evaluate the expression of some components of the Wnt pathway (beta-catenin,...
NHERF1 EXPRESSION | ACTIVATION | NHERF1 | Wnt pathway | MARKER | BETA-CATENIN | Breast Cancer | FAMILY | NUCLEAR NHERF1 | OVEREXPRESSION | RECEPTOR 2 | ONCOLOGY | COLORECTAL-CANCER | TCF1
NHERF1 EXPRESSION | ACTIVATION | NHERF1 | Wnt pathway | MARKER | BETA-CATENIN | Breast Cancer | FAMILY | NUCLEAR NHERF1 | OVEREXPRESSION | RECEPTOR 2 | ONCOLOGY | COLORECTAL-CANCER | TCF1
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 08/2013, Volume 17, Issue 8, pp. 1025 - 1037
Tryptase(+) mast cells (MCs), abundant in the invasive front of tumours, contribute to tissue remodelling. Indeed, protease‐activated receptor‐2 (PAR‐2)...
invasiveness | NHERF1 | prognostic factor | aggressiveness | Colorectal cancer | mast cell | PAR‐2 | tryptase | PAR-2 | Invasiveness | Tryptase | Prognostic factor | Mast cell | Aggressiveness | MEDICINE, RESEARCH & EXPERIMENTAL | EXCHANGER REGULATORY FACTOR-1 | TRYPSIN | PROLIFERATION | INFILTRATION | CELL BIOLOGY | BREAST-CANCER | COLON-CANCER | NUCLEAR NHERF1 | MATRIX METALLOPROTEINASES | CARCINOMA | TUMOR MICROENVIRONMENT | Tryptases - metabolism | Colorectal Neoplasms - enzymology | Intestinal Mucosa - metabolism | Prognosis | Cell Count | Humans | Middle Aged | Receptor, PAR-2 - metabolism | Cytoplasm - metabolism | Male | Mast Cells - enzymology | Phosphoproteins - metabolism | Cytoplasm - pathology | Sodium-Hydrogen Exchangers - metabolism | Models, Biological | Mast Cells - pathology | Aged, 80 and over | Adult | Female | Aged | Colorectal Neoplasms - pathology | Colorectal Neoplasms - metabolism | Intestinal Mucosa - pathology | Proteases | Correlation | Mucosa | Cloning | Colorectal carcinoma | Proteinase | Metastasis | Parameter identification | Density | Patients | Metastases | Studies | Pathology | Protease | Medical prognosis | Biomarkers | Hypoxia | Mast cells | Immunoreactivity | Adapter proteins | Tumors | Cancer | Original
invasiveness | NHERF1 | prognostic factor | aggressiveness | Colorectal cancer | mast cell | PAR‐2 | tryptase | PAR-2 | Invasiveness | Tryptase | Prognostic factor | Mast cell | Aggressiveness | MEDICINE, RESEARCH & EXPERIMENTAL | EXCHANGER REGULATORY FACTOR-1 | TRYPSIN | PROLIFERATION | INFILTRATION | CELL BIOLOGY | BREAST-CANCER | COLON-CANCER | NUCLEAR NHERF1 | MATRIX METALLOPROTEINASES | CARCINOMA | TUMOR MICROENVIRONMENT | Tryptases - metabolism | Colorectal Neoplasms - enzymology | Intestinal Mucosa - metabolism | Prognosis | Cell Count | Humans | Middle Aged | Receptor, PAR-2 - metabolism | Cytoplasm - metabolism | Male | Mast Cells - enzymology | Phosphoproteins - metabolism | Cytoplasm - pathology | Sodium-Hydrogen Exchangers - metabolism | Models, Biological | Mast Cells - pathology | Aged, 80 and over | Adult | Female | Aged | Colorectal Neoplasms - pathology | Colorectal Neoplasms - metabolism | Intestinal Mucosa - pathology | Proteases | Correlation | Mucosa | Cloning | Colorectal carcinoma | Proteinase | Metastasis | Parameter identification | Density | Patients | Metastases | Studies | Pathology | Protease | Medical prognosis | Biomarkers | Hypoxia | Mast cells | Immunoreactivity | Adapter proteins | Tumors | Cancer | Original
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 39, pp. 65730 - 65742
It has been recognized that Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) in breast cancer (BC) acts as a tumor suppressor or as an oncogenic protein,...
Immunohistochemistry | exchanger regulatory factor 1 (NHERF1) | Breast cancer | BRCA1 | PARP1 | CELLS | PHOSPHOPROTEIN-50 | DNA-DAMAGE RESPONSE | Na plus /H plus exchanger regulatory factor 1 (NHERF1) | PTEN | breast cancer | CELL BIOLOGY | NUCLEAR NHERF1 | OVEREXPRESSION | REPAIR | COLORECTAL-CANCER | PROTEIN EXPRESSION | immunohistochemistry | PROGNOSTIC-SIGNIFICANCE
Immunohistochemistry | exchanger regulatory factor 1 (NHERF1) | Breast cancer | BRCA1 | PARP1 | CELLS | PHOSPHOPROTEIN-50 | DNA-DAMAGE RESPONSE | Na plus /H plus exchanger regulatory factor 1 (NHERF1) | PTEN | breast cancer | CELL BIOLOGY | NUCLEAR NHERF1 | OVEREXPRESSION | REPAIR | COLORECTAL-CANCER | PROTEIN EXPRESSION | immunohistochemistry | PROGNOSTIC-SIGNIFICANCE
Journal Article
Cell Stress & Chaperones, ISSN 1355-8145, 9/2013, Volume 18, Issue 5, pp. 559 - 567
In a recent study, we have shown that in mammary tumors from mice lacking the Cav-1 gene, there are alterations in specific heat shock proteins as well as in...
Epithelial cells | Transgenic animals | Cell nucleus | Stromal cells | Antibodies | Breast cancer | Cell membranes | Mice | Gene expression regulation | Tumors | Biochemistry, general | Caveolin-1 | Neurosciences | NHERF1 | Oncogene | PTEN | Biomedicine general | Cell Biology | Biomedicine | Immunology | Her-2/neu | Cancer Research | β-Catenin | LOCALIZATION | PROGESTERONE-RECEPTORS | PHOSPHATASE | REGULATORY FACTOR-1 NHERF1 | CELL BIOLOGY | NUCLEAR PTEN | CARCINOGENESIS | PROTEIN EXPRESSION | beta-Catenin | BREAST-CANCER PATIENTS | MICE | Immunohistochemistry | Receptor, ErbB-2 - genetics | Humans | Receptor, ErbB-2 - metabolism | Caveolin 1 - genetics | PTEN Phosphohydrolase - metabolism | Mice, Transgenic | Phosphoproteins - metabolism | beta Catenin - metabolism | beta Catenin - genetics | Mice, Knockout | Sodium-Hydrogen Exchangers - metabolism | Caveolin 1 - metabolism | Mammary Neoplasms, Animal - pathology | Animals | MCF-7 Cells | Mammary Neoplasms, Animal - metabolism | Female | Mammary Tumor Virus, Mouse - genetics | Proto-Oncogene Proteins c-akt - metabolism | Original Paper | Her-2 | neu
Epithelial cells | Transgenic animals | Cell nucleus | Stromal cells | Antibodies | Breast cancer | Cell membranes | Mice | Gene expression regulation | Tumors | Biochemistry, general | Caveolin-1 | Neurosciences | NHERF1 | Oncogene | PTEN | Biomedicine general | Cell Biology | Biomedicine | Immunology | Her-2/neu | Cancer Research | β-Catenin | LOCALIZATION | PROGESTERONE-RECEPTORS | PHOSPHATASE | REGULATORY FACTOR-1 NHERF1 | CELL BIOLOGY | NUCLEAR PTEN | CARCINOGENESIS | PROTEIN EXPRESSION | beta-Catenin | BREAST-CANCER PATIENTS | MICE | Immunohistochemistry | Receptor, ErbB-2 - genetics | Humans | Receptor, ErbB-2 - metabolism | Caveolin 1 - genetics | PTEN Phosphohydrolase - metabolism | Mice, Transgenic | Phosphoproteins - metabolism | beta Catenin - metabolism | beta Catenin - genetics | Mice, Knockout | Sodium-Hydrogen Exchangers - metabolism | Caveolin 1 - metabolism | Mammary Neoplasms, Animal - pathology | Animals | MCF-7 Cells | Mammary Neoplasms, Animal - metabolism | Female | Mammary Tumor Virus, Mouse - genetics | Proto-Oncogene Proteins c-akt - metabolism | Original Paper | Her-2 | neu
Journal Article
Cancer Letters, ISSN 0304-3835, 07/2019, Volume 453, pp. 107 - 121
Phosphorylation of PTEN plays an important role in carcinogenesis and progression of gastric cancer. However, the underlying mechanism of PTEN phosphorylation...
PTEN | Phosphorylation | NHERF3 | Gastric cancer | Carcinogenesis | PDZ | MUTATION ANALYSIS | DOMAIN | NHERF1 | PHOSPHATASE | TENSIN-HOMOLOG PTEN | NUCLEAR PTEN | ONCOLOGY | GENES | TUMOR-SUPPRESSOR | BINDING | ALPHA-ACTININ-4 | Medical colleges | Development and progression | Stomach cancer | Cancer | Protein binding | Cell proliferation | Cell culture | Prognosis | AKT protein | Activation | Kinases | Inactivation | Phosphatase | Proteins | Carcinogens | Cell activation | Cell growth | Cell cycle | Clusters | Conflicts of interest | Inhibition | Deactivation | Patients | 1-Phosphatidylinositol 3-kinase | Domains | Signaling | Plasmids | Medical prognosis | Mutation | PTEN protein
PTEN | Phosphorylation | NHERF3 | Gastric cancer | Carcinogenesis | PDZ | MUTATION ANALYSIS | DOMAIN | NHERF1 | PHOSPHATASE | TENSIN-HOMOLOG PTEN | NUCLEAR PTEN | ONCOLOGY | GENES | TUMOR-SUPPRESSOR | BINDING | ALPHA-ACTININ-4 | Medical colleges | Development and progression | Stomach cancer | Cancer | Protein binding | Cell proliferation | Cell culture | Prognosis | AKT protein | Activation | Kinases | Inactivation | Phosphatase | Proteins | Carcinogens | Cell activation | Cell growth | Cell cycle | Clusters | Conflicts of interest | Inhibition | Deactivation | Patients | 1-Phosphatidylinositol 3-kinase | Domains | Signaling | Plasmids | Medical prognosis | Mutation | PTEN protein
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 07/2017, Volume 489, Issue 2, pp. 116 - 122
The ROMK1 K channel, a member of the ROMK channel family, is the major candidate for the K secretion pathway in the renal cortical collecting duct (CCD). ROMK1...
K+ channel | Cortical collecting duct | NHERF1 | M-1 cell | ROMK1 | channel | PROTEIN | RADIXIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | TRAFFICKING | KNOCKOUT MICE | M-1 cell | BIOPHYSICS | EZRIN | CLONING | ALDOSTERONE | ABSORPTION | POTASSIUM CHANNEL | Animals | Cells, Cultured | Potassium Channels, Inwardly Rectifying - genetics | Cell Membrane - metabolism | Mice | Kidney Tubules, Collecting - cytology | Phosphoproteins - metabolism | Potassium Channels, Inwardly Rectifying - metabolism | Sodium-Hydrogen Exchangers - metabolism
K+ channel | Cortical collecting duct | NHERF1 | M-1 cell | ROMK1 | channel | PROTEIN | RADIXIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | TRAFFICKING | KNOCKOUT MICE | M-1 cell | BIOPHYSICS | EZRIN | CLONING | ALDOSTERONE | ABSORPTION | POTASSIUM CHANNEL | Animals | Cells, Cultured | Potassium Channels, Inwardly Rectifying - genetics | Cell Membrane - metabolism | Mice | Kidney Tubules, Collecting - cytology | Phosphoproteins - metabolism | Potassium Channels, Inwardly Rectifying - metabolism | Sodium-Hydrogen Exchangers - metabolism
Journal Article
Cell Death and Disease, ISSN 2041-4889, 11/2013, Volume 4, Issue 11, pp. e904 - e904
Our purpose was to investigate whether Na+/H+ exchanger regulatory factor 1 (NHERF1) expression could be linked to prognosis in invasive breast carcinomas....
Breast cancer | NHERF1 expression | Prognosis | EBP50 | MERLIN | DOMAIN | EXCHANGER REGULATORY FACTOR-1 | PROTEIN | breast cancer | CELL-PROLIFERATION | prognosis | CELL BIOLOGY | OVEREXPRESSION | INVASION | COLORECTAL-CANCER | BINDING | Immunohistochemistry | Humans | Middle Aged | Male | Phosphoproteins - genetics | Phosphoproteins - metabolism | Breast Neoplasms - metabolism | Sodium-Hydrogen Exchangers - metabolism | Breast Neoplasms - genetics | Cell Nucleus - metabolism | Breast Neoplasms - pathology | Adult | Female | Sodium-Hydrogen Exchangers - genetics | Aged | In Vitro Techniques | Original
Breast cancer | NHERF1 expression | Prognosis | EBP50 | MERLIN | DOMAIN | EXCHANGER REGULATORY FACTOR-1 | PROTEIN | breast cancer | CELL-PROLIFERATION | prognosis | CELL BIOLOGY | OVEREXPRESSION | INVASION | COLORECTAL-CANCER | BINDING | Immunohistochemistry | Humans | Middle Aged | Male | Phosphoproteins - genetics | Phosphoproteins - metabolism | Breast Neoplasms - metabolism | Sodium-Hydrogen Exchangers - metabolism | Breast Neoplasms - genetics | Cell Nucleus - metabolism | Breast Neoplasms - pathology | Adult | Female | Sodium-Hydrogen Exchangers - genetics | Aged | In Vitro Techniques | Original
Journal Article
Histopathology, ISSN 0309-0167, 11/2009, Volume 55, Issue 5, pp. 600 - 608
Aims: To determine the role of Na+/H+ exchanger regulatory factor (NHERF1) in breast cancerogenesis and progression. Methods and results: NHERF1 expression...
breast cancer | NHERF1 | HER2/neu | immunohistochemistry | immunofluorescence | Immunohistochemistry | Breast cancer | HER2neu | Immunofluorescence | CELLS | METASTASIS | EXCHANGER REGULATORY FACTOR | PROLIFERATION | PATHOLOGY | MOESIN-BINDING PHOSPHOPROTEIN-50 | CELL BIOLOGY | OVEREXPRESSION | RECEPTOR TYROSINE KINASES | EPITHELIA | HER2 | NA+/H+ EXCHANGER | ASSOCIATION | neu | Receptor, ErbB-2 - biosynthesis | Phosphoproteins - biosynthesis | Biomarkers, Tumor - analysis | Carcinoma in Situ - pathology | Humans | In Situ Hybridization, Fluorescence | Breast Neoplasms - metabolism | Breast Neoplasms - pathology | Fluorescent Antibody Technique | Carcinoma, Ductal, Breast - pathology | Female | Sodium-Hydrogen Exchangers - biosynthesis | Carcinoma in Situ - metabolism | Neoplasm Staging | Carcinoma, Ductal, Breast - metabolism | Metastasis
breast cancer | NHERF1 | HER2/neu | immunohistochemistry | immunofluorescence | Immunohistochemistry | Breast cancer | HER2neu | Immunofluorescence | CELLS | METASTASIS | EXCHANGER REGULATORY FACTOR | PROLIFERATION | PATHOLOGY | MOESIN-BINDING PHOSPHOPROTEIN-50 | CELL BIOLOGY | OVEREXPRESSION | RECEPTOR TYROSINE KINASES | EPITHELIA | HER2 | NA+/H+ EXCHANGER | ASSOCIATION | neu | Receptor, ErbB-2 - biosynthesis | Phosphoproteins - biosynthesis | Biomarkers, Tumor - analysis | Carcinoma in Situ - pathology | Humans | In Situ Hybridization, Fluorescence | Breast Neoplasms - metabolism | Breast Neoplasms - pathology | Fluorescent Antibody Technique | Carcinoma, Ductal, Breast - pathology | Female | Sodium-Hydrogen Exchangers - biosynthesis | Carcinoma in Situ - metabolism | Neoplasm Staging | Carcinoma, Ductal, Breast - metabolism | Metastasis
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2011, Volume 130, Issue 2, pp. 409 - 420
The luminal B subtype represents a group of high proliferating estrogen receptor positive breast cancers which are associated with a poor prognosis. Genes...
SLC9A3R1 | NHERF1 | Prognosis | Medicine & Public Health | EBP50 | Luminal B type breast cancer | Oncology | Microarray analysis | CELLS | DOMAIN | PROTEIN | EXCHANGER REGULATORY FACTOR | IDENTIFICATION | RECEPTOR TYROSINE KINASES | MOLECULAR PORTRAITS | HISTOLOGIC GRADE | ONCOLOGY | PI3K PATHWAY | Carcinoma, Ductal, Breast - genetics | Multivariate Analysis | Multigene Family | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Drug Resistance, Neoplasm | Gene Expression Profiling | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Biomarkers, Tumor - metabolism | Carcinoma, Ductal, Breast - pathology | Female | Sodium-Hydrogen Exchangers - genetics | Gene Expression | Receptors, Estrogen - genetics | Antineoplastic Agents, Hormonal - pharmacology | Genetic Association Studies | Proportional Hazards Models | Phosphoproteins - genetics | Carcinoma, Ductal, Breast - diagnosis | Disease-Free Survival | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Biomarkers, Tumor - genetics | Breast Neoplasms - diagnosis | DNA microarrays | Analysis | Genes | Estrogen | Breast cancer | Genetic aspects | Gene expression | Cancer | Estrogen receptors | AKT protein | Data processing | Multivariate analysis | ErbB-2 protein | Survival | 1-Phosphatidylinositol 3-kinase | Signal transduction | scaffolds | Tumors
SLC9A3R1 | NHERF1 | Prognosis | Medicine & Public Health | EBP50 | Luminal B type breast cancer | Oncology | Microarray analysis | CELLS | DOMAIN | PROTEIN | EXCHANGER REGULATORY FACTOR | IDENTIFICATION | RECEPTOR TYROSINE KINASES | MOLECULAR PORTRAITS | HISTOLOGIC GRADE | ONCOLOGY | PI3K PATHWAY | Carcinoma, Ductal, Breast - genetics | Multivariate Analysis | Multigene Family | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Drug Resistance, Neoplasm | Gene Expression Profiling | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Biomarkers, Tumor - metabolism | Carcinoma, Ductal, Breast - pathology | Female | Sodium-Hydrogen Exchangers - genetics | Gene Expression | Receptors, Estrogen - genetics | Antineoplastic Agents, Hormonal - pharmacology | Genetic Association Studies | Proportional Hazards Models | Phosphoproteins - genetics | Carcinoma, Ductal, Breast - diagnosis | Disease-Free Survival | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Biomarkers, Tumor - genetics | Breast Neoplasms - diagnosis | DNA microarrays | Analysis | Genes | Estrogen | Breast cancer | Genetic aspects | Gene expression | Cancer | Estrogen receptors | AKT protein | Data processing | Multivariate analysis | ErbB-2 protein | Survival | 1-Phosphatidylinositol 3-kinase | Signal transduction | scaffolds | Tumors
Journal Article
Pflügers Archiv - European Journal of Physiology, ISSN 0031-6768, 12/2014, Volume 466, Issue 12, pp. 2269 - 2278
Pseudomonas aeruginosa infections of the airway cells decrease apical expression of both wild-type (wt) and F508del CFTR through the inhibition of apical...
Phosphorylation | Biomedicine | NHERF1 | Human Physiology | Ubquitination | Lung infection | CFTR | FLAGELLIN | PHYSIOLOGY | BRONCHIAL EPITHELIAL-CELLS | KINASE | FACTOR-I | BACTERIAL PATHOGENS | TRANSMEMBRANE-CONDUCTANCE-REGULATOR | FUNCTIONAL EXPRESSION | INFLAMMATION | CYSTIC-FIBROSIS | Bronchi - microbiology | Cell Line | Lung - microbiology | Humans | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Phosphoproteins - genetics | Lung - cytology | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Respiratory Mucosa - microbiology | Pseudomonas Infections - metabolism | Ubiquitination | Animals | Bronchi - metabolism | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Pseudomonas aeruginosa | Sodium-Hydrogen Exchangers - genetics | Lung - metabolism | Mice | Protein Processing, Post-Translational | Mutation | Respiratory Mucosa - metabolism | Bronchi - cytology | Proteins | Post-translational modification | Cystic fibrosis
Phosphorylation | Biomedicine | NHERF1 | Human Physiology | Ubquitination | Lung infection | CFTR | FLAGELLIN | PHYSIOLOGY | BRONCHIAL EPITHELIAL-CELLS | KINASE | FACTOR-I | BACTERIAL PATHOGENS | TRANSMEMBRANE-CONDUCTANCE-REGULATOR | FUNCTIONAL EXPRESSION | INFLAMMATION | CYSTIC-FIBROSIS | Bronchi - microbiology | Cell Line | Lung - microbiology | Humans | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Phosphoproteins - genetics | Lung - cytology | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Respiratory Mucosa - microbiology | Pseudomonas Infections - metabolism | Ubiquitination | Animals | Bronchi - metabolism | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Pseudomonas aeruginosa | Sodium-Hydrogen Exchangers - genetics | Lung - metabolism | Mice | Protein Processing, Post-Translational | Mutation | Respiratory Mucosa - metabolism | Bronchi - cytology | Proteins | Post-translational modification | Cystic fibrosis
Journal Article
Molecular Biotechnology, ISSN 1073-6085, 6/2015, Volume 57, Issue 6, pp. 549 - 557
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide and cytology is often the only diagnostic approach. Na+/H+ exchanger...
Biochemistry, general | Protein Science | Human Genetics | Immunohistochemistry | Biotechnology | Chemistry | NHERF1 | EBP50 | Non-small cell lung cancer | Biological Techniques | Fine needle aspiration cytology | Cell Biology | PROTEIN | PROGNOSTIC-FACTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOESIN-BINDING PHOSPHOPROTEIN-50 | NUCLEAR NHERF1 | BREAST-CANCER | OVEREXPRESSION | SPECIMENS | EPITHELIA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MUTATIONS | ASSOCIATION | Carcinoma, Non-Small-Cell Lung - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Male | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Paraffin Embedding | Biopsy, Fine-Needle | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Aged | Research | Lung cancer, Non-small cell | Oncology, Experimental | Cancer | Biomarkers | Gene expression | Lung cancer
Biochemistry, general | Protein Science | Human Genetics | Immunohistochemistry | Biotechnology | Chemistry | NHERF1 | EBP50 | Non-small cell lung cancer | Biological Techniques | Fine needle aspiration cytology | Cell Biology | PROTEIN | PROGNOSTIC-FACTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOESIN-BINDING PHOSPHOPROTEIN-50 | NUCLEAR NHERF1 | BREAST-CANCER | OVEREXPRESSION | SPECIMENS | EPITHELIA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MUTATIONS | ASSOCIATION | Carcinoma, Non-Small-Cell Lung - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Male | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Paraffin Embedding | Biopsy, Fine-Needle | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Aged | Research | Lung cancer, Non-small cell | Oncology, Experimental | Cancer | Biomarkers | Gene expression | Lung cancer
Journal Article
BMC CANCER, ISSN 1471-2407, 03/2012, Volume 12, Issue 1, pp. 106 - 106
Background: Traditional determinants proven to be of prognostic importance in breast cancer include the TNM staging, histological grade, proliferative...
NHERF1 | VEGFR1 | SIGNATURES | EXCHANGER REGULATORY FACTOR | Breast cancer | CHEMOTHERAPY | Peritumoral Vascular Invasion | HISTOLOGIC GRADE | Histological grade | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | TUMOR-METASTASIS | TERM-FOLLOW-UP | INDEX | NA+/H+ EXCHANGER | Nottingham Prognostic Index | MOLECULAR-BASIS | Immunohistochemistry | Multivariate Analysis | Prognosis | Neoplasm Invasiveness | Humans | Middle Aged | Male | Phosphoproteins - metabolism | Breast Neoplasms - metabolism | Sodium-Hydrogen Exchangers - metabolism | Young Adult | Breast Neoplasms - pathology | Fluorescent Antibody Technique | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Aged | Neoplasm Staging | Cohort Studies | Nottingham prognostic index | Peritumoral vascular invasion
NHERF1 | VEGFR1 | SIGNATURES | EXCHANGER REGULATORY FACTOR | Breast cancer | CHEMOTHERAPY | Peritumoral Vascular Invasion | HISTOLOGIC GRADE | Histological grade | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | TUMOR-METASTASIS | TERM-FOLLOW-UP | INDEX | NA+/H+ EXCHANGER | Nottingham Prognostic Index | MOLECULAR-BASIS | Immunohistochemistry | Multivariate Analysis | Prognosis | Neoplasm Invasiveness | Humans | Middle Aged | Male | Phosphoproteins - metabolism | Breast Neoplasms - metabolism | Sodium-Hydrogen Exchangers - metabolism | Young Adult | Breast Neoplasms - pathology | Fluorescent Antibody Technique | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Aged | Neoplasm Staging | Cohort Studies | Nottingham prognostic index | Peritumoral vascular invasion
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 08/2015, Volume 16, Issue 8, pp. 1140 - 1147
Cellular resistance in advanced gastric cancer (GC) might be related to function of multidrug resistance (MDR) proteins. The adaptor protein NHERF1 (Na + /H +...
multi-drug resistance | immunohistochemistry | gastric cancer | chemotherapy | NHERF1/EBP50 | predictive factor | Immunohistochemistry | Chemotherapy | Multi-drug resistance | Predictive factor | Gastric cancer | PROTEIN | ADVANCED ESOPHAGOGASTRIC CANCER | DRUG-RESISTANCE | FOLINIC ACID | P-GLYCOPROTEIN | BREAST-CANCER | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | COLORECTAL-CANCER | MULTIDRUG-RESISTANCE | UP-REGULATION | Capecitabine - administration & dosage | Humans | Middle Aged | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Stomach Neoplasms - metabolism | Male | Reference Values | Stomach Neoplasms - pathology | Treatment Outcome | Epirubicin - administration & dosage | Stomach Neoplasms - drug therapy | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Organoplatinum Compounds - administration & dosage | Cell Nucleus - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Adult | Female | Aged | Retrospective Studies | Drug Resistance, Neoplasm - drug effects
multi-drug resistance | immunohistochemistry | gastric cancer | chemotherapy | NHERF1/EBP50 | predictive factor | Immunohistochemistry | Chemotherapy | Multi-drug resistance | Predictive factor | Gastric cancer | PROTEIN | ADVANCED ESOPHAGOGASTRIC CANCER | DRUG-RESISTANCE | FOLINIC ACID | P-GLYCOPROTEIN | BREAST-CANCER | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | COLORECTAL-CANCER | MULTIDRUG-RESISTANCE | UP-REGULATION | Capecitabine - administration & dosage | Humans | Middle Aged | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Stomach Neoplasms - metabolism | Male | Reference Values | Stomach Neoplasms - pathology | Treatment Outcome | Epirubicin - administration & dosage | Stomach Neoplasms - drug therapy | Phosphoproteins - metabolism | Sodium-Hydrogen Exchangers - metabolism | Organoplatinum Compounds - administration & dosage | Cell Nucleus - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Adult | Female | Aged | Retrospective Studies | Drug Resistance, Neoplasm - drug effects
Journal Article
American Journal of Respiratory Cell and Molecular Biology, ISSN 1044-1549, 01/2010, Volume 44, Issue 1, pp. 91 - 98
To date, three β-adrenoceptor (β-AR) subtypes have been identified, but only β(1)-ARs and β(2)-ARs have been characterized in human lungs. Moreover, β(2)-ARs...
Bronchus | Cystic fibrosis | β-adrenergic receptor | NHERF1 | Epithelium | Receptors, Adrenergic, beta-3 - drug effects | Albuterol - pharmacology | Humans | Middle Aged | Male | Receptors, Adrenergic, beta-2 - drug effects | Phosphoproteins - metabolism | RNA, Messenger - metabolism | Case-Control Studies | Sodium-Hydrogen Exchangers - metabolism | Bronchi - drug effects | Young Adult | Cystic Fibrosis Transmembrane Conductance Regulator - drug effects | Prazosin - pharmacology | Receptors, Adrenergic, beta-3 - genetics | Bronchi - metabolism | Adult | Female | Sodium-Hydrogen Exchangers - genetics | Receptors, Adrenergic, beta-1 - drug effects | Thiazolidines - pharmacology | Cell Line | Colforsin - pharmacology | Cystic Fibrosis - metabolism | Receptors, Adrenergic, beta-2 - genetics | Gene Expression Regulation | Adrenergic beta-Agonists - pharmacology | Receptors, Adrenergic, beta-1 - metabolism | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Phosphoproteins - genetics | Receptors, Adrenergic, beta-3 - metabolism | Dobutamine - pharmacology | Receptors, Adrenergic, beta-2 - metabolism | Cystic Fibrosis - genetics | Benzoates - pharmacology | Receptors, Adrenergic, beta-1 - genetics | Aged
Bronchus | Cystic fibrosis | β-adrenergic receptor | NHERF1 | Epithelium | Receptors, Adrenergic, beta-3 - drug effects | Albuterol - pharmacology | Humans | Middle Aged | Male | Receptors, Adrenergic, beta-2 - drug effects | Phosphoproteins - metabolism | RNA, Messenger - metabolism | Case-Control Studies | Sodium-Hydrogen Exchangers - metabolism | Bronchi - drug effects | Young Adult | Cystic Fibrosis Transmembrane Conductance Regulator - drug effects | Prazosin - pharmacology | Receptors, Adrenergic, beta-3 - genetics | Bronchi - metabolism | Adult | Female | Sodium-Hydrogen Exchangers - genetics | Receptors, Adrenergic, beta-1 - drug effects | Thiazolidines - pharmacology | Cell Line | Colforsin - pharmacology | Cystic Fibrosis - metabolism | Receptors, Adrenergic, beta-2 - genetics | Gene Expression Regulation | Adrenergic beta-Agonists - pharmacology | Receptors, Adrenergic, beta-1 - metabolism | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Phosphoproteins - genetics | Receptors, Adrenergic, beta-3 - metabolism | Dobutamine - pharmacology | Receptors, Adrenergic, beta-2 - metabolism | Cystic Fibrosis - genetics | Benzoates - pharmacology | Receptors, Adrenergic, beta-1 - genetics | Aged
Journal Article